Chemoinformaics analysis of (10S,11S)-Pterosin C
| Molecular Weight | 234.295 | nRot | 2 |
| Heavy Atom Molecular Weight | 216.151 | nRig | 11 |
| Exact Molecular Weight | 234.126 | nRing | 2 |
| Solubility: LogS | -2.073 | nHRing | 0 |
| Solubility: LogP | 1.283 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 37.7883 |
| nHD | 2 | BPOL | 18.9257 |
| QED | 0.819 |
| Synth | 3.532 |
| Natural Product Likeliness | 2.161 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.047 |
| HIA | 0.013 |
| CACO-2 | -4.661 |
| MDCK | 0.00000956 |
| BBB | 0.821 |
| PPB | 0.722481 |
| VDSS | 0.98 |
| FU | 0.247939 |
| CYP1A2-inh | 0.47 |
| CYP1A2-sub | 0.901 |
| CYP2c19-inh | 0.028 |
| CYP2c19-sub | 0.851 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.58 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.337 |
| CYP3a4-inh | 0.055 |
| CYP3a4-sub | 0.535 |
| CL | 4.682 |
| T12 | 0.259 |
| hERG | 0.014 |
| Ames | 0.085 |
| ROA | 0.093 |
| SkinSen | 0.112 |
| Carcinogencity | 0.04 |
| EI | 0.101 |
| Respiratory | 0.344 |
| NR-Aromatase | 0.106 |
| Antiviral | Yes |
| Prediction | 0.587725 |